OC036—Impact Of Cyp2c9 Polymorphisms On The Vulnerability To Pharmacokinetic Drug–Drug Interactions During Acenocoumarol Treatment
Authors:
- V. RollasonVRV. Rollason
- L. GschwindLGL. Gschwind
- F. BoehlenFBF. Boehlen
- M. RebsamenMRM. Rebsamen
- C. CombescureCCC. Combescure
- M. GrünenwaldMGM. Grünenwald
- A. MattheyAMA. Matthey
- P. BonnabryPBP. Bonnabry
- P. DayerPDP. Dayer
- J.A. DesmeulesJ.A. Desmeules
Open Access
- 31 August 2013
- journal article
- abstracts
- Published by Elsevier in Clinical Therapeutics
- Vol. 35 (8) , e14